Clinical Trial Update: A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the combination of cemiplimab and fianlimab in people with clear cell renal cell carcinoma, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Fianlimab (fianlimab)
• Libtayo (cemiplimab) (cemiplimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: RECRUITING